For Harvard Stem Cell Institute Co-Director and Xander University Professor Douglas Melton, whose lab pioneered the science behind the therapy, the trial marked the most recent turning point in a decades-long effort to understand and treat the disease. In a conversation with the Gazette, Melton discussed the science behind the advance, the ...
New Report Highlights Diabetes Research Advances and Achievements
In addition, the report provides an update on the Pathway to Stop Diabetes® (Pathway) program, which pairs talented early-career scientists with mentorship from world-renowned diabetes scientists to drive research innovation free from traditional project constraints. This year, through the Pathway program, ADA dedicated over $4.8 million ...
Breakthrough diabetes study could lead to end of regular insulin
The Baker Heart and Diabetes Institute researchers are optimistic their work could potentially help people living with insulin-dependent type 2 diabetes. The research has been published in a ...
New cause of diabetes discovered, offering potential ...
Researchers have identified an enzyme that blocks insulin produced in the body -- a discovery that could provide a new target to treat diabetes. The study focuses on nitric oxide, a compound that ...
These are the tools for providing top-notch diabetes care to everyone
A new scientific study published recently in Nature Medicine describes how the research team, led by Maahs and Priya Prahalad, MD, PhD, have implemented major advances in intensive diabetes management. First, they tackled equity issues to ensure the latest diabetes technology got into the hands of every patient as soon as they were diagnosed.
Diabetes
Cells destroy donated mitochondria to build blood vessels. Organelles called mitochondria are transferred to blood-vessel-forming cells by support cells. Unexpectedly, these mitochondria are ...
Review Articles
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) September 28 2022
Diabetes: Following the science in the search for a cure
Making insulin-resistant cells more sensitive to insulin is another goal of novel therapeutics for diabetes. In preclinical research, insulin sensitivity has been improved with gene therapy ...
Milestones in diabetes
In type 1 diabetes, a progressive and immune-mediated deterioration of β-cells occurs within pancreatic islets, eventually leading to an almost complete absence of insulin secretion. In type 2 ...
Study unlocks potential breakthrough in type 1 diabetes treatment
Study unlocks potential breakthrough in type 1 diabetes treatment. Cell barcoding strategy enables high-throughput materials screening. Credit: Nature Biomedical Engineering (2023). DOI: 10.1038 ...
Diabetes News -- ScienceDaily
Learn about early diabetes symptoms, diabetic diet information, diabetes care, type 1 diabetes, insulin resistance and type 2 diabetes. Read the latest medical research on diabetes.
Recent Advances
Recent Advances. ADA-funded researchers use the money from their awards to conduct critical diabetes research. In time, they publish their findings in order to inform fellow scientists of their results, which ensures that others will build upon their work. Ultimately, this cycle drives advances to prevent diabetes and to help people burdened by it.
The ADA's 2022 Standards of Medical Care in Diabetes Update
A group of clinical practice and research experts developed the Standards of Care by reviewing new evidence about all the scientific fields that are involved in effectively managing diabetes. Important Updates. This year, the ADA revised nearly all the sections in the Standards of Care, including recommendations for. diabetes screening
Current Advances in the Management of Diabetes Mellitus
Nanotechnology in diabetes research has played several roles in improving the outcome of diabetic management in diabetics through the deployment of novel nanotechnology ... Bakay M., Pandey R., Hakonarson H. Genes involved in type 1 diabetes: An update. Genes. 2013; 4:499-521. doi: 10.3390/genes4030499. [PMC free article] [Google ...
What's new in endocrinology and diabetes mellitus
In a trial in 655 adults with type 1 diabetes (mean A1C approximately 7.6 percent), participants were randomly assigned to basal insulin therapy with once-weekly insulin icodec or once-daily insulin degludec . After 26 weeks, the mean reduction in A1C was similar in the icodec and degludec groups (-0.47 and -0.51 percentage points, respectively).
Metabolomics in Diabetes and Diabetic Complications: Insights ...
The increasing prevalence of diabetes and its complications, such as cardiovascular and kidney disease, remains a huge burden globally. Identification of biomarkers for the screening, diagnosis, and prognosis of diabetes and its complications and better understanding of the molecular pathways involved in the development and progression of diabetes can facilitate individualized prevention and ...
Cell therapy fails to slow type 1 diabetes, but safety is ...
Tolerance is the holy grail in calming autoimmune disease, a truce in the immune system's faulty battle against the body's own fabric. In type 1 diabetes, immune fighters attack beta cells in ...
New advances in type 1 diabetes
Type 1 diabetes is an autoimmune condition resulting in insulin deficiency and eventual loss of pancreatic β cell function requiring lifelong insulin therapy. Since the discovery of insulin more than 100 years ago, vast advances in treatments have improved care for many people with type 1 diabetes. Ongoing research on the genetics and immunology of type 1 diabetes and on interventions to ...
Newsroom
At the Diabetes Research Institute and Foundation, we have one goal: to find a cure for diabetes. Read the latest DRI news and press releases. For media inquiries and requests for interviews with leading experts in the field of diabetes research, please contact: Michael Myers Chief Communications Officer. Paulina Castro
Diabetes Core Update Podcasts
Diabetes Core Update is a monthly audio podcast devoted to presenting and discussing the latest clinically relevant articles from ADA's four scholarly journals— Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum—as well as notable articles from other journals related to diabetes research and care. Each episode is approximately 30 minutes long and includes discussion of 4 ...
Important Updates to the Standards of Medical Care in Diabetes—2022
The online version of the Standards of Care now includes any research updates or policy changes that are approved throughout 2022. The complete, annotated Standards of Care, which includes updates made today, can be accessed online at Diabetes Care. The Abridged Standards of Medical Care in Diabetes has also been updated and can be accessed ...
Type 2 diabetes
Type 2 diabetes mellitus, the most frequent subtype of diabetes, is a disease characterized by high levels of blood glucose (hyperglycaemia). ... Research Open Access 27 Apr 2024 npj Digital Medicine.
Research Projects
Research Projects. Print. The Division of Diabetes Translation (DDT) conducts and supports studies, often in collaboration with partners, to develop and apply sound science to reduce the burden of diabetes and to address the research needs of DDT programs and the diabetes community.
JDRF T1D Research
Our Strategy: Curing T1D. Improving Lives. Our research has two core objectives: Cures by restoring the body's ability to make insulin and stopping T1D before it occurs or providing insulin independence through replacement with insulin producing cells, and Improving Lives by keeping people with T1D as healthy as possible until cures are found ...
Current and future therapies for type 1 diabetes
Although research into type 1 diabetes prevention and disease modification continues to produce encouraging data, none of the approaches discussed above appears sufficiently effective alone in preventing or managing type 1 diabetes. Future endeavours will, therefore, require a novel focus, leveraging prior experience with regard to the ...
Brian earns his first grant
(February, 2024) Brian List won a Provost's Undergraduate Research Fellowship award to study the damaging effects of high glucose on beta-cell metabolism. His first of many grants! Finding and fixing the earliest signs of failure in insulin-producing beta-cells ... Update footer. Nunemaker Lab: Finding and fixing the earliest signs of failure ...
Type 1 diabetes
Type 1 diabetes (also known as diabetes mellitus) is an autoimmune disease in which immune cells attack and destroy the insulin-producing cells of the pancreas. The loss of insulin leads to the ...
Investments in Primary Care Research for 2021 and 2022
In the second phase, the research team will randomize 282 participants to receive either usual care for diabetes or care supplemented with the i-Matter tool. Outcomes include mean reduction in blood sugar levels, changes in patient adherence to lifestyle and medication recommendations, and patient-provider communication.
News & Updates
American Diabetes Association ® Names Three Awardees for $4.875 Million in 2019 Pathway to Stop Diabetes Research Grants - February 15, 2019. Three ADA Pathway Grant Awardees' Collaborative Breakthrough: Analysis Describing the Genetic Link Between Beta (β) Cell Function and Type 2 Diabetes Published in Cell Reports - January 15, 2019.
FDA issues recall for diabetes app after over 200 reported injuries
In its App Store "Version History," Tandem wrote the 2.7.1 patch was for "Overall app performance updates." UPDATE 5/9/24 1:22PM: Tandem Diabetes Care has provided the following statement :
IMAGES
COMMENTS
For Harvard Stem Cell Institute Co-Director and Xander University Professor Douglas Melton, whose lab pioneered the science behind the therapy, the trial marked the most recent turning point in a decades-long effort to understand and treat the disease. In a conversation with the Gazette, Melton discussed the science behind the advance, the ...
In addition, the report provides an update on the Pathway to Stop Diabetes® (Pathway) program, which pairs talented early-career scientists with mentorship from world-renowned diabetes scientists to drive research innovation free from traditional project constraints. This year, through the Pathway program, ADA dedicated over $4.8 million ...
The Baker Heart and Diabetes Institute researchers are optimistic their work could potentially help people living with insulin-dependent type 2 diabetes. The research has been published in a ...
Researchers have identified an enzyme that blocks insulin produced in the body -- a discovery that could provide a new target to treat diabetes. The study focuses on nitric oxide, a compound that ...
A new scientific study published recently in Nature Medicine describes how the research team, led by Maahs and Priya Prahalad, MD, PhD, have implemented major advances in intensive diabetes management. First, they tackled equity issues to ensure the latest diabetes technology got into the hands of every patient as soon as they were diagnosed.
Cells destroy donated mitochondria to build blood vessels. Organelles called mitochondria are transferred to blood-vessel-forming cells by support cells. Unexpectedly, these mitochondria are ...
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) September 28 2022
Making insulin-resistant cells more sensitive to insulin is another goal of novel therapeutics for diabetes. In preclinical research, insulin sensitivity has been improved with gene therapy ...
In type 1 diabetes, a progressive and immune-mediated deterioration of β-cells occurs within pancreatic islets, eventually leading to an almost complete absence of insulin secretion. In type 2 ...
Study unlocks potential breakthrough in type 1 diabetes treatment. Cell barcoding strategy enables high-throughput materials screening. Credit: Nature Biomedical Engineering (2023). DOI: 10.1038 ...
Learn about early diabetes symptoms, diabetic diet information, diabetes care, type 1 diabetes, insulin resistance and type 2 diabetes. Read the latest medical research on diabetes.
Recent Advances. ADA-funded researchers use the money from their awards to conduct critical diabetes research. In time, they publish their findings in order to inform fellow scientists of their results, which ensures that others will build upon their work. Ultimately, this cycle drives advances to prevent diabetes and to help people burdened by it.
A group of clinical practice and research experts developed the Standards of Care by reviewing new evidence about all the scientific fields that are involved in effectively managing diabetes. Important Updates. This year, the ADA revised nearly all the sections in the Standards of Care, including recommendations for. diabetes screening
Nanotechnology in diabetes research has played several roles in improving the outcome of diabetic management in diabetics through the deployment of novel nanotechnology ... Bakay M., Pandey R., Hakonarson H. Genes involved in type 1 diabetes: An update. Genes. 2013; 4:499-521. doi: 10.3390/genes4030499. [PMC free article] [Google ...
In a trial in 655 adults with type 1 diabetes (mean A1C approximately 7.6 percent), participants were randomly assigned to basal insulin therapy with once-weekly insulin icodec or once-daily insulin degludec . After 26 weeks, the mean reduction in A1C was similar in the icodec and degludec groups (-0.47 and -0.51 percentage points, respectively).
The increasing prevalence of diabetes and its complications, such as cardiovascular and kidney disease, remains a huge burden globally. Identification of biomarkers for the screening, diagnosis, and prognosis of diabetes and its complications and better understanding of the molecular pathways involved in the development and progression of diabetes can facilitate individualized prevention and ...
Tolerance is the holy grail in calming autoimmune disease, a truce in the immune system's faulty battle against the body's own fabric. In type 1 diabetes, immune fighters attack beta cells in ...
Type 1 diabetes is an autoimmune condition resulting in insulin deficiency and eventual loss of pancreatic β cell function requiring lifelong insulin therapy. Since the discovery of insulin more than 100 years ago, vast advances in treatments have improved care for many people with type 1 diabetes. Ongoing research on the genetics and immunology of type 1 diabetes and on interventions to ...
At the Diabetes Research Institute and Foundation, we have one goal: to find a cure for diabetes. Read the latest DRI news and press releases. For media inquiries and requests for interviews with leading experts in the field of diabetes research, please contact: Michael Myers Chief Communications Officer. Paulina Castro
Diabetes Core Update is a monthly audio podcast devoted to presenting and discussing the latest clinically relevant articles from ADA's four scholarly journals— Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum—as well as notable articles from other journals related to diabetes research and care. Each episode is approximately 30 minutes long and includes discussion of 4 ...
The online version of the Standards of Care now includes any research updates or policy changes that are approved throughout 2022. The complete, annotated Standards of Care, which includes updates made today, can be accessed online at Diabetes Care. The Abridged Standards of Medical Care in Diabetes has also been updated and can be accessed ...
Type 2 diabetes mellitus, the most frequent subtype of diabetes, is a disease characterized by high levels of blood glucose (hyperglycaemia). ... Research Open Access 27 Apr 2024 npj Digital Medicine.
Research Projects. Print. The Division of Diabetes Translation (DDT) conducts and supports studies, often in collaboration with partners, to develop and apply sound science to reduce the burden of diabetes and to address the research needs of DDT programs and the diabetes community.
Our Strategy: Curing T1D. Improving Lives. Our research has two core objectives: Cures by restoring the body's ability to make insulin and stopping T1D before it occurs or providing insulin independence through replacement with insulin producing cells, and Improving Lives by keeping people with T1D as healthy as possible until cures are found ...
Although research into type 1 diabetes prevention and disease modification continues to produce encouraging data, none of the approaches discussed above appears sufficiently effective alone in preventing or managing type 1 diabetes. Future endeavours will, therefore, require a novel focus, leveraging prior experience with regard to the ...
(February, 2024) Brian List won a Provost's Undergraduate Research Fellowship award to study the damaging effects of high glucose on beta-cell metabolism. His first of many grants! Finding and fixing the earliest signs of failure in insulin-producing beta-cells ... Update footer. Nunemaker Lab: Finding and fixing the earliest signs of failure ...
Type 1 diabetes (also known as diabetes mellitus) is an autoimmune disease in which immune cells attack and destroy the insulin-producing cells of the pancreas. The loss of insulin leads to the ...
In the second phase, the research team will randomize 282 participants to receive either usual care for diabetes or care supplemented with the i-Matter tool. Outcomes include mean reduction in blood sugar levels, changes in patient adherence to lifestyle and medication recommendations, and patient-provider communication.
American Diabetes Association ® Names Three Awardees for $4.875 Million in 2019 Pathway to Stop Diabetes Research Grants - February 15, 2019. Three ADA Pathway Grant Awardees' Collaborative Breakthrough: Analysis Describing the Genetic Link Between Beta (β) Cell Function and Type 2 Diabetes Published in Cell Reports - January 15, 2019.
In its App Store "Version History," Tandem wrote the 2.7.1 patch was for "Overall app performance updates." UPDATE 5/9/24 1:22PM: Tandem Diabetes Care has provided the following statement :